or Try an Advanced Search...

    Plaque Psoriasis Stocks List

    Symbol Grade Name % Change
    ARQT B Arcutis Biotherapeutics, Inc. -0.79
    BIIB F Biogen Idec Inc. -0.06
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Immunology Psoriasis Alopecia Areata Alzheimer's Disease Atopic Dermatitis Atopy Autoimmune Disease Autoimmune Disorders Biotechnology Cd20 Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Degenerative Disease Dermatitis Dermatological Diseases Disability Eczema Hemophilia Idiopathic Pulmonary Fibrosis

    Related ETFs - A few ETFs which own one or more of the above listed Plaque Psoriasis stocks.

    Symbol Grade Name Weight
    BIS B ProShares UltraShort Nasdaq Biotechnology 6.12
    PBE D PowerShares Dynamic Biotech & Genome 4.21
    BBH D Market Vectors Biotech ETF 3.86
    MNTL D Tema Neuroscience and Mental Health ETF 3.57
    MEDX F Horizon Kinetics Medical ETF 3.08
    View all Plaque Psoriasis ETFs...
    Compare ETFs
    Compare BBH to MEDX Compare MNTL to MEDX Compare PBE to MEDX

        Plaque Psoriasis Stocks Recent News

        Date Stock Title
        Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
        Nov 20 ARQT Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 200-Day Moving Average
        Nov 20 ARQT Arcutis Biotherapeutics, Inc. (ARQT) Crossed Above the 50-Day Moving Average: What That Means for Investors
        Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
        Nov 19 ARQT Bears are Losing Control Over Arcutis Biotherapeutics (ARQT), Here's Why It's a 'Buy' Now
        Nov 19 ARQT Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 20-Day Moving Average
        Nov 19 BIIB Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
        Nov 18 BIIB Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
        Nov 18 BIIB Needham downgrades Biogen on slow growth of Alzheimer's drug
        Nov 18 BIIB Biogen cut to hold by Needham on lack of catalysts, slow Leqembi sales
        Nov 18 ARQT Arcutis Biotherapeutics: What Lies Ahead
        Nov 18 BIIB Samsung Bioepis and Biogen Receive European Commission (EC) Approval for Aflibercept Biosimilar, OPUVIZ™
        Nov 18 BIIB Is Biogen Inc. (BIIB) A Cheap NASDAQ Stock To Invest In Now?
        Nov 15 BIIB Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe
        Nov 15 ARQT Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
        Nov 14 BIIB European committee takes a second look at Alzheimer's drug and now says it should be approved
        Nov 14 BIIB 5 Healthcare Stocks to Buy in a Beaten-Up Sector
        Nov 14 BIIB Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
        Nov 14 BIIB Biogen gains as Eisai wins EU nod for Alzheimer’s drug
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Immunology Psoriasis Alopecia Areata Alzheimer's Disease Atopic Dermatitis Atopy Autoimmune Disease Autoimmune Disorders Biotechnology Cd20 Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Degenerative Disease Dermatitis Dermatological Diseases Disability Eczema Hemophilia Idiopathic Pulmonary Fibrosis
        Plaque Psoriasis

        Plaque psoriasis is a chronic autoimmune skin condition that causes raised, red, scaly patches to appear on the skin. It is the most common form of psoriasis, affecting around 80% of people with the condition. Plaque psoriasis can appear anywhere on the body, but is most commonly found on the elbows, knees, scalp, and lower back.

        Browse All Tags